Sp804
GASTRIC PREMALIGNANT LESIONS: KEY PATHOLOGICAL CONCEPTS FOR OPTIMIZING CLINICAL MANAGMENT
Date
May 20, 2024
Presenter
Tracks
Related Products
IMPLICATION OF HYPUSINATION IN HELICOBACTER PYLORI-INDUCED GASTRIC CARCINOGENESIS
INTRODUCTION: Dysregulated polyamine metabolism during _Helicobacter pylori_ infection can lead to the development of gastric cancer. The polyamine spermine is back-converted to spermidine by spermine oxidase (SMOX). We have shown that _H…
TARGETING HYPOXIA-INDUCIBLE FACTOR-1 ALPHA (HIF-1α) SUPPRESSES GASTRIC CARCINOGENESIS VIA ATTENUATION OF BOTH <i>HELICOBACTER PYLORI </i>VIRULENCE AND PROINFLAMMATORY HOST RESPONSES
INTRODUCTION. Our previous study reported a significant increase in metachronous recurrence of early gastric cancer after endoscopic submucosal dissection due to CD44v9-positive cancer stem-like cells in _H. pylori_-infected stomach tissue (_BR. J. CANCER_ 109:379, 2013)…
ENDOGENOUS GLUCOCORTICOIDS PROTECT FROM HELICOBACTER-INDUCED AUTOIMMUNE GASTRITIS
Gastric cancer is the 4th leading cause of cancer deaths worldwide. _Helicobacter pylori _infection is the primary risk factor for gastric cancer. In the United States, gastric cancer rates have been declining for several decades, likely due to reduced _H. pylori _infection rates…
EVALUATION OF THE SAFETY AND EFFICACY OF EFLORNITHINE (DIFLUOROMETHYLORNITHINE, DFMO) IN PATIENTS WITH GASTRIC PREMALIGNANT CONDITIONS IN THE HIGH INCIDENCE AREAS OF LATIN AMERICA
BACKGROUND. Gastric adenocarcinoma (GAC) is the third leading global cause of cancer mortality and the leading infection-associated cancer. In the U.S., GAC represents a major cancer disparity, with incidence rates 2-3X in non-white populations…
